AtaiBeckley (ATAI) Receivables - Other (2020 - 2026)

AtaiBeckley (ATAI) posted Receivables - Other of $326000.0 for Q3 2021, down 63.78% sequentially from $900000.0 in Q4 2020.

AtaiBeckley (ATAI) Receivables - Other (2020 - 2026) Analysis & Trends

AtaiBeckley's Receivables - Other history runs 1 years deep, the most recent figure standing at $600000.0 for Q1 2026.

Quarterly Receivables - Other changed N/A year-over-year to $326000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $326000.0 (changed N/A YoY) and the FY2020 annual result came in at $900000.0, changed N/A from the prior year.
Receivables - Other for Q1 2026 stood at $600000.0.
Over five years, Receivables - Other peaked at $900000.0 in Q4 2020 and troughed at $326000.0 in Q3 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn
10	AtaiBeckley	2.69 Bn	2.69 Bn	-

Download Data